Supporting Prescribing in Irish Primary Care: General Practice Pharmacist Study

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 14, 2017

Primary Completion Date

March 10, 2020

Study Completion Date

March 10, 2020

Conditions
PolypharmacyMultimorbidity
Interventions
OTHER

Main Study

The pharmacist will participate in the management of repeat prescribing and undertake medication reviews (which will address high risk prescribing and potentially inappropriate prescribing, deprescribing and cost-effective and generic prescribing) with adult patients. Pharmacists will also provide prescribing advice regarding the use of preferred drugs, undertake clinical audits, join practice team meetings and facilitate practice-based education. Throughout the six-month intervention period, anonymised practice-level medication (e.g. medication changes) and cost data will be collected.

OTHER

PROM Study

For this, a sub-set of patients (n=200) aged ≥65 years on ≥10 repeat medicines will be recruited and invited to a medication review with the pharmacist. PROMs and healthcare utilisation data will be collected using patient questionnaires and a six-week follow-up review with these patients will also be conducted.

Trial Locations (1)

2

Royal College of Surgeons in Ireland, Dublin

All Listed Sponsors
collaborator

Health Service Executive, Ireland

OTHER

collaborator

University of Dublin, Trinity College

OTHER

lead

Royal College of Surgeons, Ireland

OTHER

NCT04326062 - Supporting Prescribing in Irish Primary Care: General Practice Pharmacist Study | Biotech Hunter | Biotech Hunter